Comparison of cofilin‑1 and Twist‑1 protein expression in human non‑small cell lung cancer tissues

  • Authors:
    • Chun‑Yuan Chang
    • Shi‑Long Chang
    • Jyh‑Der Leu
    • Yu‑Chan Chang
    • Michael Hsiao
    • Liang‑Ting Lin
    • Han‑Nan Lin
    • Yi‑Jang Lee
  • View Affiliations

  • Published online on: June 10, 2019     https://doi.org/10.3892/or.2019.7193
  • Pages: 805-816
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Metastasis is the primary cause of mortality in patients with non‑small cell lung cancer (NSCLC). Actin cytoskeletal reorganization is usually accompanied by the epithelial‑mesenchymal transition (EMT)‑induced invasion and metastasis of cancer cells. In the present study, expression levels of the actin‑associated protein cofilin‑1 and of the pivotal EMT molecule Twist‑1 were determined in NSCLC tissues. Using lung cancer tissue arrays, the identification of 67.4% of tissue spots that exhibited reciprocal levels of cofilin‑1 and Twist‑1 was achieved by immunohistochemical (IHC) staining. This reciprocal expression pattern was also detected in 21 out of 25 clinicopathological NSCLC tissue sections, and in 10 out of 15 NSCLC cell lines. In addition, high levels of cofilin‑1 and low levels of Twist‑1 accounted for 80 and 71.5% of the reciprocal expression pattern in tissue arrays and clinicopathological tissue samples, respectively. This pattern was also detected in normal lung tissues, stage I and II lung cancer tissues, and adenocarcinoma subtypes of NSCLC tissues. Although cofilin‑1 and Twist‑1 were expressed inversely, a positive correlation of these two proteins was present in normal lung tissues and lung tumor tissues. Furthermore, enforced expression of cofilin‑1 suppressed the expression level of Twist‑1 in NSCLC H1299 cells. An on‑line Kaplan‑Meier survival analytic tool allowed access to a public microarray dataset with a maximum of 1,926 NSCLC samples. The analysis revealed that high expression levels of both cofilin‑1 (CFL1) and Twist‑1 (TWIST1) genes were associated with decreased survival of NSCLC patients, notably with regard to the adenocarcinoma subtype. The analysis was conducted using the multivariate Cox regression model. Although the reciprocal association of the expression levels of cofilin‑1 and Twist‑1 with the survival rate of NSCLC patients requires additional information, it may be a significant indicator of the progression of NSCLC.

References

1 

Devesa SS, Bray F, Vizcaino AP and Parkin DM: International lung cancer trends by histologic type: Male:Female differences diminishing and adenocarcinoma rates rising. Int J Cancer. 117:294–299. 2005. View Article : Google Scholar : PubMed/NCBI

2 

Thomas A, Liu SV, Subramaniam DS and Giaccone G: Refining the treatment of NSCLC according to histological and molecular subtypes. Nat Rev Clin Oncol. 12:511–526. 2015. View Article : Google Scholar : PubMed/NCBI

3 

Morgensztern D, Ng SH, Gao F and Govindan R: Trends in stage distribution for patients with non-small cell lung cancer: A National Cancer Database survey. J Thorac Oncol. 5:29–33. 2010. View Article : Google Scholar : PubMed/NCBI

4 

Mahmood MQ, Ward C, Muller HK, Sohal SS and Walters EH: Epithelial mesenchymal transition (EMT) and non-small cell lung cancer (NSCLC): A mutual association with airway disease. Med Oncol. 34:452017. View Article : Google Scholar : PubMed/NCBI

5 

Zeng J, Zhan P, Wu G, Yang W, Liang W, Lv T and Song Y: Prognostic value of Twist in lung cancer: Systematic review and meta-analysis. Transl Lung Cancer Res. 4:236–241. 2015.PubMed/NCBI

6 

Zhang YQ, Wei XL, Liang YK, Chen WL, Zhang F, Bai JW, Qiu SQ, Du CW, Huang WH and Zhang GJ: Over-expressed twist associates with markers of epithelial mesenchymal transition and predicts poor prognosis in breast cancers via ERK and Akt activation. PLoS One. 10:e01358512015. View Article : Google Scholar : PubMed/NCBI

7 

Škovierová H, Okajčeková T, Strnádel J, Vidomanová E and Halašová E: Molecular regulation of epithelial-to-mesenchymal transition in tumorigenesis (Review). Int J Mol Med. 41:1187–1200. 2018.PubMed/NCBI

8 

Morris HT and Machesky LM: Actin cytoskeletal control during epithelial to mesenchymal transition: Focus on the pancreas and intestinal tract. Br J Cancer. 112:613–620. 2015. View Article : Google Scholar : PubMed/NCBI

9 

Shankar J and Nabi IR: Correction: Actin cytoskeleton regulation of epithelial mesenchymal transition in metastatic cancer cells. PLoS One. 10:e01327592015. View Article : Google Scholar : PubMed/NCBI

10 

Peng JM, Bera R, Chiou CY, Yu MC, Chen TC, Chen CW, Wang TR, Chiang WL, Chai SP, Wei Y, et al: Actin cytoskeleton remodeling drives epithelial-mesenchymal transition for hepatoma invasion and metastasis in mice. Hepatology. 67:2226–2243. 2018. View Article : Google Scholar : PubMed/NCBI

11 

Haynes J, Srivastava J, Madson N, Wittmann T and Barber DL: Dynamic actin remodeling during epithelial-mesenchymal transition depends on increased moesin expression. Mol Biol Cell. 22:4750–4764. 2011. View Article : Google Scholar : PubMed/NCBI

12 

Huang D, Cao L and Zheng S: CAPZA1 modulates EMT by regulating actin cytoskeleton remodelling in hepatocellular carcinoma. J Exp Clin Cancer Res. 36:132017. View Article : Google Scholar : PubMed/NCBI

13 

Izdebska M, Zielińska W, Grzanka D and Gagat M: The role of actin dynamics and actin-binding proteins expression in epithelial-to-mesenchymal transition and its association with cancer progression and evaluation of possible therapeutic targets. BioMed Res Int. 2018:45783732018. View Article : Google Scholar : PubMed/NCBI

14 

Prunier C, Prudent R, Kapur R, Sadoul K and Lafanechère L: LIM kinases: Cofilin and beyond. Oncotarget. 8:41749–41763. 2017. View Article : Google Scholar : PubMed/NCBI

15 

Wang W, Eddy R and Condeelis J: The cofilin pathway in breast cancer invasion and metastasis. Nat Rev Cancer. 7:429–440. 2007. View Article : Google Scholar : PubMed/NCBI

16 

Wang H, Tao L, Jin F, Gu H, Dai X, Ni T, Feng J, Ding Y, Xiao W, Qian Y and Liu Y: Cofilin 1 induces the epithelial-mesenchymal transition of gastric cancer cells by promoting cytoskeletal rearrangement. Oncotarget. 8:39131–39142. 2017.PubMed/NCBI

17 

Sousa-Squiavinato ACM, Rocha MR, Barcellos-de-Souza P, de Souza WF and Morgado-Diaz JA: Cofilin-1 signaling mediates epithelial-mesenchymal transition by promoting actin cytoskeleton reorganization and cell-cell adhesion regulation in colorectal cancer cells. Biochim Biophys Acta Mol Cell Res. 1866:418–429. 2019. View Article : Google Scholar : PubMed/NCBI

18 

Tsai CH, Lin LT, Wang CY, Chiu YW, Chou YT, Chiu SJ, Wang HE, Liu RS, Wu CY, Chan PC, et al: Over-expression of cofilin-1 suppressed growth and invasion of cancer cells is associated with up-regulation of let-7 microRNA. Biochim Biophys Acta. 1852:851–861. 2015. View Article : Google Scholar : PubMed/NCBI

19 

Tan EJ, Thuault S, Caja L, Carletti T, Heldin CH and Moustakas A: Regulation of transcription factor Twist expression by the DNA architectural protein high mobility group A2 during epithelial-to-mesenchymal transition. J Biol Chem. 287:7134–7145. 2012. View Article : Google Scholar : PubMed/NCBI

20 

Morishita A, Zaidi MR, Mitoro A, Sankarasharma D, Szabolcs M, Okada Y, D'Armiento J and Chada K: HMGA2 is a driver of tumor metastasis. Cancer Res. 73:4289–4299. 2013. View Article : Google Scholar : PubMed/NCBI

21 

Wang CY, Tsai CH, Chang CY, Liao MJ, Liu RS and Lee YJ: Over-expression of cofilin-1 suppressed mobility of lung cancer cells is associated with down-regulation of SNAIL-1 and induction of Let-7. Clin Oncol. 1:10152016.

22 

Györffy B, Lanczky A, Eklund AC, Denkert C, Budczies J, Li Q and Szallasi Z: An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients. Breast Cancer Res Treat. 123:725–731. 2010. View Article : Google Scholar : PubMed/NCBI

23 

Győrffy B, Surowiak P, Budczies J and Lánczky A: Online survival analysis software to assess the prognostic value of biomarkers using transcriptomic data in non-small-cell lung cancer. PLoS One. 8:e822412013. View Article : Google Scholar : PubMed/NCBI

24 

Tsai CH, Chiu SJ, Liu CC, Sheu TJ, Hsieh CH, Keng PC and Lee YJ: Regulated expression of cofilin and the consequent regulation of p27(kip1) are essential for G(1) phase progression. Cell Cycle. 8:2365–2374. 2009. View Article : Google Scholar : PubMed/NCBI

25 

Lee YJ, Mazzatti DJ, Yun Z and Keng PC: Inhibition of invasiveness of human lung cancer cell line H1299 by over-expression of cofilin. Cell Biol Int. 29:877–883. 2005. View Article : Google Scholar : PubMed/NCBI

26 

Tran PT, Shroff EH, Burns TF, Thiyagarajan S, Das ST, Zabuawala T, Chen J, Cho YJ, Luong R, Tamayo P, et al: Twist1 suppresses senescence programs and thereby accelerates and maintains mutant Kras-induced lung tumorigenesis. PLoS Genet. 8:e10026502012. View Article : Google Scholar : PubMed/NCBI

27 

Rangel MP, Antonangelo L, Acencio MMP, Faria CS, de Sá VK, Leão PS, Farhat C, Fabro AT, Longatto Filho A, Reis RM, et al: Detection of sputum cofilin-1 as indicator of malignancy. Braz J Med Biol Res. 51:e71382018. View Article : Google Scholar : PubMed/NCBI

28 

Zheng Y, Fang Y, Li S and Zheng B: Detection of plasma cofilin protein for diagnosis of lung cancer. Nan Fang Yi Ke Da Xue Xue Bao. 33:1551–1553. 2013.(In Chinese). PubMed/NCBI

29 

Yang WH, Lan HY, Huang CH, Tai SK, Tzeng CH, Kao SY, Wu KJ, Hung MC and Yang MH: RAC1 activation mediates Twist1-induced cancer cell migration. Nat Cell Biol. 14:366–374. 2012. View Article : Google Scholar : PubMed/NCBI

30 

Lee YJ and Keng PC: Studying the effects of actin cytoskeletal destabilization on cell cycle by cofilin overexpression. Mol Biotechnol. 31:1–10. 2005. View Article : Google Scholar : PubMed/NCBI

31 

Zhao Z, Rahman MA, Chen ZG and Shin DM: Multiple biological functions of Twist1 in various cancers. Oncotarget. 8:20380–20393. 2017.PubMed/NCBI

32 

Boland S, Boisvieux-Ulrich E, Houcine O, Baeza-Squiban A, Pouchelet M, Schoëvaërt D and Marano F: TGF beta 1 promotes actin cytoskeleton reorganization and migratory phenotype in epithelial tracheal cells in primary culture. J Cell Sci. 109:2207–2219. 1996.PubMed/NCBI

33 

Wójciak-Stothard B, Entwistle A, Garg R and Ridley AJ: Regulation of TNF-alpha-induced reorganization of the actin cytoskeleton and cell-cell junctions by Rho, Rac, and Cdc42 in human endothelial cells. J Cell Physiol. 176:150–165. 1998. View Article : Google Scholar : PubMed/NCBI

34 

Akiyama T and Kawasaki Y: Wnt signalling and the actin cytoskeleton. Oncogene. 25:7538–7544. 2006. View Article : Google Scholar : PubMed/NCBI

35 

Ménard L, Parker PJ and Kermorgant S: Receptor tyrosine kinase c-Met controls the cytoskeleton from different endosomes via different pathways. Nat Commun. 5:39072014. View Article : Google Scholar : PubMed/NCBI

36 

Britton GJ, Ambler R, Clark DJ, Hill EV, Tunbridge HM, McNally KE, Burton BR, Butterweck P, Sabatos-Peyton C, Hampton-O'Neil LA, et al: PKCθ links proximal T cell and Notch signaling through localized regulation of the actin cytoskeleton. Elife. 6:e200032017. View Article : Google Scholar : PubMed/NCBI

37 

Zieseniss A: Hypoxia and the modulation of the actin cytoskeleton-emerging interrelations. Hypoxia (Auckl). 2:11–21. 2014. View Article : Google Scholar : PubMed/NCBI

38 

Duan X, Liu J, Dai XX, Liu HL, Cui XS, Kim NH, Wang ZB, Wang Q and Sun SC: Rho-GTPase effector ROCK phosphorylates cofilin in actin-meditated cytokinesis during mouse oocyte meiosis. Biol Reprod. 90:372014. View Article : Google Scholar : PubMed/NCBI

39 

Alexander NR, Tran NL, Rekapally H, Summers CE, Glackin C and Heimark RL: N-cadherin gene expression in prostate carcinoma is modulated by integrin-dependent nuclear translocation of Twist1. Cancer Res. 66:3365–3369. 2006. View Article : Google Scholar : PubMed/NCBI

40 

Müller CB, de Barros RL, Castro MA, Lopes FM, Meurer RT, Roehe A, Mazzini G, Ulbrich-Kulczynski JM, Dal-Pizzol F, Fernandes MC, et al: Validation of cofilin-1 as a biomarker in non-small cell lung cancer: Application of quantitative method in a retrospective cohort. J Cancer Res Clin Oncol. 137:1309–1316. 2011. View Article : Google Scholar : PubMed/NCBI

41 

Li M, Zhang X, Xu X, Wu J, Hu K, Guo X and Zhang P: Clinicopathological and prognostic significance of Twist overexpression in NSCLC. Oncotarget. 9:14642–14651. 2018.PubMed/NCBI

42 

Yap CT, Simpson TI, Pratt T, Price DJ and Maciver SK: The motility of glioblastoma tumour cells is modulated by intracellular cofilin expression in a concentration-dependent manner. Cell Motil Cytoskeleton. 60:153–165. 2005. View Article : Google Scholar : PubMed/NCBI

Related Articles

Journal Cover

August 2019
Volume 42 Issue 2

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Chang, C., Chang, S., Leu, J., Chang, Y., Hsiao, M., Lin, L. ... Lee, Y. (2019). Comparison of cofilin‑1 and Twist‑1 protein expression in human non‑small cell lung cancer tissues. Oncology Reports, 42, 805-816. https://doi.org/10.3892/or.2019.7193
MLA
Chang, C., Chang, S., Leu, J., Chang, Y., Hsiao, M., Lin, L., Lin, H., Lee, Y."Comparison of cofilin‑1 and Twist‑1 protein expression in human non‑small cell lung cancer tissues". Oncology Reports 42.2 (2019): 805-816.
Chicago
Chang, C., Chang, S., Leu, J., Chang, Y., Hsiao, M., Lin, L., Lin, H., Lee, Y."Comparison of cofilin‑1 and Twist‑1 protein expression in human non‑small cell lung cancer tissues". Oncology Reports 42, no. 2 (2019): 805-816. https://doi.org/10.3892/or.2019.7193